The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers
Abstract
The pharmaceutical industry is exposed to severe conditions: while a typical R&D process lasts up to 13 years, only one out of 10,000 substances becomes a marketable product. In addition, markets for pharmaceutical products tend to become more fragmented, leading to an increased risk of market failure. At the same time, R&D productivity has been deteriorating for several years. The number of new drug approvals is constantly declining, while R&D expenditures are escalating as a result of high investments in new drug discovery technologies and more complex clinical studies. As a response, pharmaceutical firms have started to focus on balancing the right size and structure of their R&D activities. This leads to several organizational trends: (1) novel management of technologies; (2) R&D internationalization; and (3) open innovation modes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology
Powell, W. W., Koput, K. W., & Smith-Doerr, L. (1996) · Administrative Science Quarterly · doi:10.2307/2393988 · Cited by 8,499
Cited by
Open Innovation in Practice: An Analysis of Strategic Approaches to Technology Transactions
Lichtenthaler, U. (2008) · IEEE Transactions on Engineering Management · doi:10.1109/tem.2007.912932 · Cited by 633
Shepherd, D. A., Patzelt, H., & Wolfe, M. (2011) · Academy of Management Journal · doi:10.5465/amj.2010.0102 · Cited by 485
WHY 'OPEN INNOVATION' IS OLD WINE IN NEW BOTTLES
TROTT, P., & HARTMANN, D. (2009) · International Journal of Innovation Management · doi:10.1142/s1363919609002509 · Cited by 474
Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis
Bianchi, M., Cavaliere, A., Chiaroni, D., Frattini, F., & Chiesa, V. (2011) · Technovation · doi:10.1016/j.technovation.2010.03.002 · Cited by 469
Outbound open innovation and its effect on firm performance: examining environmental influences
Lichtenthaler, U. (2009) · R&D Management · doi:10.1111/j.1467-9310.2009.00561.x · Cited by 456
Metadata
- Authors
- Gassmann, O., & Reepmeyer, G.
- Venue
- Creativity and Innovation Management
- Publisher
- Wiley
- Published
- 2005-08-31
- Volume
- 14
- Issue
- 3
- Pages
- 233-245
- ISSN
- 0963-1690 (ISSN-L)
- 1467-8691
- OpenAlex
- W1985020560
- Cited by
- 166
- References
- 1
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers. https://app.cochat.ai/papers/10.1111/j.1467-8691.2005.00344.x
- The paper
- Gassmann, O., & Reepmeyer, G. (2005). Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers. Creativity and Innovation Management. https://doi.org/10.1111/j.1467-8691.2005.00344.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.